Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1951 (LINC01951) is a long non-coding RNA gene located in intergenic regions, meaning it does not overlap with any protein-coding genes. It belongs to the class of long intergenic non-coding RNAs (lincRNAs), which are typically more than 200 nucleotides long and do not code for proteins. LINC01951, also known as CTC-281M20.1, is transcribed but its specific biological function, expression pattern, or disease association has not yet been characterized in detail. In general, lincRNAs like LINC01951 are involved in regulation of gene expression and may play roles in epigenetic modification, transcription, and post-transcriptional regulation. Some lincRNAs are implicated in cancer and other diseases, but there is no published evidence that LINC01951 itself is currently recognized as a validated therapeutic target, interacts with drugs, or is used as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1951 (LINC01951).